A Metabolome-Wide Study of Dry Eye Disease Reveals Serum Androgens as Biomarkers
Open Access
- 1 April 2017
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 124 (4) , 505-511
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Metabolomic markers reveal novel pathways of ageing and early development in human populationsInternational Journal of Epidemiology, 2013
- Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA) – Recent reportsSteroids, 2012
- The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian GlandInvestigative Ophthalmology & Visual Science, 2011
- The Human Serum MetabolomePLOS ONE, 2011
- Reading the metabolic fine printEMBO Reports, 2009
- Validation and Repeatability of a Short Questionnaire for Dry Eye SyndromeAmerican Journal of Ophthalmology, 2006
- Combined Esterified Estrogen and Methyltestosterone Treatment for Dry Eye Syndrome in Postmenopausal WomenAmerican Journal of Ophthalmology, 2005
- Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndromeArthritis Care & Research, 2004
- Is Complete Androgen Insensitivity Syndrome Associated with Alterations in the Meibomian Gland and Ocular Surface?Cornea, 2003
- Are Twins and Singletons Comparable? A Study of Disease-related and Lifestyle Characteristics in Adult WomenTwin Research, 2001